BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 24, 15:59Prev. Close
43.28
Open Price
43.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Balaxi Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 11.04 | 10.90 | 10.18 | 10.00 | 10.00 | |
| Total Share Capital | 11.04 | 10.90 | 10.18 | 10.00 | 10.00 | |
| Reserves and Surplus | 116.81 | 106.88 | 71.63 | 47.91 | 33.25 | |
| Total Reserves and Surplus | 116.81 | 106.88 | 71.63 | 47.91 | 33.25 | |
| Total Shareholders Funds | 127.85 | 121.55 | 92.11 | 57.91 | 43.25 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.90 | 1.00 | 1.10 | 0.04 | 0.01 | |
| Other Long Term Liabilities | 1.80 | 1.74 | 1.69 | 0.00 | 0.00 | |
| Long Term Provisions | 0.13 | 0.04 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 2.83 | 2.78 | 2.79 | 0.04 | 0.01 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 30.38 | 13.96 | 10.75 | 1.93 | 3.51 | |
| Trade Payables | 8.96 | 12.44 | 17.26 | 17.20 | 16.65 | |
| Other Current Liabilities | 4.43 | 3.64 | 6.82 | 0.09 | 0.08 | |
| Short Term Provisions | 0.00 | 0.00 | 0.00 | 4.75 | 5.44 | |
| Total Current Liabilities | 43.76 | 30.04 | 34.83 | 23.97 | 25.67 | |
| Total Capital And Liabilities | 174.45 | 154.36 | 129.72 | 81.92 | 68.92 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 6.67 | 7.10 | 7.89 | 2.20 | 0.69 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 22.07 | 2.31 | 2.83 | 0.57 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 28.75 | 9.40 | 10.73 | 2.77 | 0.69 | |
| Non-Current Investments | 25.07 | 19.88 | 19.54 | 19.61 | 19.54 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 1.02 | 2.18 | 0.44 | 5.46 | 0.02 | |
| Total Non-Current Assets | 54.84 | 31.46 | 30.70 | 27.84 | 20.25 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 0.00 | 0.84 | 1.49 | 0.00 | 0.02 | |
| Trade Receivables | 89.92 | 76.76 | 78.29 | 53.18 | 48.13 | |
| Cash And Cash Equivalents | 28.69 | 44.06 | 17.88 | 0.84 | 0.48 | |
| Short Term Loans And Advances | 0.08 | 0.15 | 0.22 | 0.05 | 0.05 | |
| OtherCurrentAssets | 0.91 | 1.09 | 1.14 | 0.00 | 0.00 | |
| Total Current Assets | 119.60 | 122.90 | 99.02 | 54.08 | 48.67 | |
| Total Assets | 174.45 | 154.36 | 129.72 | 81.92 | 68.92 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 1.88 | 3.98 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 54.34 | 64.81 | 80.24 | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 25.07 | 19.88 | 19.54 | 19.61 | 19.54 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.08.2025
Balaxi Pharma Consolidated June 2025 Net Sales at Rs 70.74 crore, up 7.8% Y-o-Y
06.08.2025
Balaxi Pharma Standalone June 2025 Net Sales at Rs 16.71 crore, down 12.18% Y-o-Y
24.06.2025
Balaxi Pharma Standalone March 2025 Net Sales at Rs 9.65 crore, down 39.33% Y-o-Y
20.02.2025
Balaxi Pharma Consolidated December 2024 Net Sales at Rs 73.29 crore, up 20.57% Y-o-Y
12.08.2025
Balaxi Pharma Consolidated June 2025 Net Sales at Rs 70.74 crore, up 7.8% Y-o-Y
06.08.2025
Balaxi Pharma Standalone June 2025 Net Sales at Rs 16.71 crore, down 12.18% Y-o-Y
24.06.2025
Balaxi Pharma Standalone March 2025 Net Sales at Rs 9.65 crore, down 39.33% Y-o-Y
20.02.2025
Balaxi Pharma Consolidated December 2024 Net Sales at Rs 73.29 crore, up 20.57% Y-o-Y
15.06.2017
24.04.2017
18.04.2017
18.04.2017
14.02.2017
13.02.2017
12.02.2017
09.12.2016